{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:51:28Z","timestamp":1792594288584,"version":"4.5.0"},"reference-count":400,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["TG\/18\/4\/33770"],"award-info":[{"award-number":["TG\/18\/4\/33770"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/17\/61\/33473"],"award-info":[{"award-number":["FS\/17\/61\/33473"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000735","name":"University of Cambridge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["RG85315"],"award-info":[{"award-number":["RG85315"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C33616\/A27229"],"award-info":[{"award-number":["C33616\/A27229"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT107715\/Z\/15\/Z"],"award-info":[{"award-number":["WT107715\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203814\/Z\/16\/A"],"award-info":[{"award-number":["203814\/Z\/16\/A"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.pharmr.2026.100130","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T02:59:45Z","timestamp":1773457185000},"page":"100130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["International Union of Basic and Clinical Pharmacology. CXXI. Apelin receptor pharmacology in the human cardiovascular system and emerging clinical applications"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2096-3117","authenticated-orcid":false,"given":"Anthony P.","family":"Davenport","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6212-9518","authenticated-orcid":false,"given":"Duuamene","family":"Nyimanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8129-7242","authenticated-orcid":false,"given":"Robyn G.C.","family":"Macrae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4673-1602","authenticated-orcid":false,"given":"Rhoda E.","family":"Kuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9774-1643","authenticated-orcid":false,"given":"Fiona A.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9128-6603","authenticated-orcid":false,"given":"Neeraj","family":"Dhaun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9254-7040","authenticated-orcid":false,"given":"Janet J.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1-2","key":"10.1016\/j.pharmr.2026.100130_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0378-1119(93)90495-O","article-title":"A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11","volume":"136","author":"O'Dowd","year":"1993","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cellsig.2004.09.018","article-title":"Apelin signalling: a promising pathway from cloning to pharmacology","volume":"17","author":"Masri","year":"2005","journal-title":"Cell Signal"},{"issue":"2\u20133","key":"10.1016\/j.pharmr.2026.100130_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0167-0115(01)00236-1","article-title":"The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism","volume":"99","author":"Tatemoto","year":"2001","journal-title":"Regul Pept"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/HYPERTENSIONAHA.109.134619","article-title":"[Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease","volume":"54","author":"Maguire","year":"2009","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib6","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1124\/pr.112.007179","article-title":"International union of basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands","volume":"65","author":"Davenport","year":"2013","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/pr.110.002949","article-title":"International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function","volume":"62","author":"Pitkin","year":"2010","journal-title":"Pharmacol Rev"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.devcel.2013.11.002","article-title":"ELABELA: a hormone essential for heart development signals via the apelin receptor","volume":"27","author":"Chng","year":"2013","journal-title":"Dev Cell"},{"issue":"6172","key":"10.1016\/j.pharmr.2026.100130_bib9","doi-asserted-by":"crossref","first-page":"1248636","DOI":"10.1126\/science.1248636","article-title":"Toddler: an embryonic signal that promotes cell movement via Apelin receptors","volume":"343","author":"Pauli","year":"2014","journal-title":"Science"},{"issue":"28","key":"10.1016\/j.pharmr.2026.100130_bib10","doi-asserted-by":"crossref","first-page":"21061","DOI":"10.1074\/jbc.M908417199","article-title":"Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin","volume":"275","author":"Hosoya","year":"2000","journal-title":"J Biol Chem"},{"issue":"34","key":"10.1016\/j.pharmr.2026.100130_bib11","doi-asserted-by":"crossref","first-page":"10163","DOI":"10.1021\/bi030049s","article-title":"Structural and functional study of the apelin-13 peptide, an endogenous ligand of the HIV-1 coreceptor, APJ","volume":"42","author":"Fan","year":"2003","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib12","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1046\/j.1471-4159.2003.01587.x","article-title":"Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin","volume":"84","author":"Medhurst","year":"2003","journal-title":"J Neurochem"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100130_bib13","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.116.023218","article-title":"Elabela\/Toddler is an endogenous agonist of the apelin APJ receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension","volume":"135","author":"Yang","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2026.100130_bib14","doi-asserted-by":"crossref","first-page":"1139121","DOI":"10.3389\/fendo.2023.1139121","article-title":"Expanding the apelin receptor pharmacological toolbox using novel fluorescent ligands","volume":"14","author":"Williams","year":"2023","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib15","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.bjp.0703939","article-title":"[(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man","volume":"132","author":"Katugampola","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib16","first-page":"547","article-title":"Evaluation of novel cyclic analogues of apelin","volume":"22","author":"Hamada","year":"2008","journal-title":"Int J Mol Med"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100130_bib17","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1016\/j.bmcl.2014.08.045","article-title":"The design and implementation of a generic lipopeptide scanning platform to enable the identification of \u201clocally acting\u201d agonists for the apelin receptor","volume":"24","author":"McKeown","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100130_bib18","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1021\/acs.jmedchem.0c01941","article-title":"Constraining the side chain of C-terminal amino acids in Apelin-13 greatly increases affinity, modulates signaling, and improves the pharmacokinetic profile","volume":"64","author":"Tr\u00e2n","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2026.100130_bib19","doi-asserted-by":"crossref","first-page":"715095","DOI":"10.3389\/fphar.2021.715095","article-title":"LIT01-196, a metabolically stable Apelin-17 analog, normalizes blood pressure in hypertensive DOCA-salt rats via a NO synthase-dependent mechanism","volume":"12","author":"Flahault","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41467-020-20560-y","article-title":"A metabolically stable apelin-17 analog decreases AVP-induced antidiuresis and improves hyponatremia","volume":"12","author":"Flahault","year":"2021","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100130_bib21","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1039\/D1MD00120E","article-title":"Metabolically stable apelin-analogues, incorporating cyclohexylalanine and homoarginine, as potent apelin receptor activators","volume":"12","author":"Fernandez","year":"2021","journal-title":"RSC Med Chem"},{"issue":"suppl 6","key":"10.1016\/j.pharmr.2026.100130_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/bcpt.13227","article-title":"Apelin peptides linked to anti-serum albumin domain antibodies retain affinity in vitro and are efficacious receptor agonists in vivo","volume":"126","author":"Read","year":"2020","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax7379","article-title":"Structure-guided discovery of a single-domain antibody agonist against human apelin receptor","volume":"6","author":"Ma","year":"2020","journal-title":"Sci Adv"},{"issue":"30","key":"10.1016\/j.pharmr.2026.100130_bib24","doi-asserted-by":"crossref","first-page":"18261","DOI":"10.1074\/jbc.M115.648238","article-title":"Apela regulates fluid homeostasis by binding to the APJ receptor to activate Gi signaling","volume":"290","author":"Deng","year":"2015","journal-title":"J Biol Chem"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100130_bib25","doi-asserted-by":"crossref","first-page":"16028","DOI":"10.1021\/acs.jmedchem.0c01913","article-title":"PEGylated and acylated elabela analogues show enhanced receptor binding, prolonged stability, and remedy of acute kidney injury","volume":"63","author":"Wang","year":"2020","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib26","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/HYPERTENSIONAHA.114.05099","article-title":"Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist","volume":"65","author":"Brame","year":"2015","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1021\/acs.jmedchem.1c01708","article-title":"Size-reduced macrocyclic analogues of [Pyr1]-apelin-13 showing negative G\u03b112 bias still produce prolonged cardiac effects","volume":"65","author":"Tran","year":"2022","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib28","doi-asserted-by":"crossref","first-page":"10714","DOI":"10.1038\/s41467-024-55381-w","article-title":"Structural and functional determination of peptide versus small molecule ligand binding at the apelin receptor","volume":"15","author":"Williams","year":"2024","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib29","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1096\/fj.09-140715","article-title":"Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist","volume":"24","author":"Iturrioz","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmr.2026.100130_bib30","author":"Khan"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib31","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1021\/acs.jmedchem.0c01448","article-title":"Pyrazole agonist of the apelin receptor improves symptoms of metabolic syndrome in mice","volume":"64","author":"Narayanan","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2026.100130_bib32","doi-asserted-by":"crossref","first-page":"116789","DOI":"10.1016\/j.bmc.2022.116789","article-title":"Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin receptor","volume":"66","author":"Narayanan","year":"2022","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100130_bib33","doi-asserted-by":"crossref","first-page":"126955","DOI":"10.1016\/j.bmcl.2020.126955","article-title":"Discovery and SAR of aryl hydroxy pyrimidinones as potent small molecule agonists of the GPCR APJ","volume":"30","author":"Myers","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007351","article-title":"In vitro and in vivo evaluation of a small-molecule APJ (apelin receptor) agonist, BMS-986224, as a potential treatment for heart failure","volume":"14","author":"Gargalovic","year":"2021","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100130_bib35","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1021\/acsmedchemlett.1c00385","article-title":"Identification of 6-hydroxypyrimidin-4(1H)-one-3-carboxamides as potent and orally active APJ receptor agonists","volume":"12","author":"Pi","year":"2021","journal-title":"ACS Med Chem Lett"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib36","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1021\/acs.jmedchem.0c01878","article-title":"Discovery of a hydroxypyridinone APJ receptor agonist as a clinical candidate","volume":"64","author":"Johnson","year":"2021","journal-title":"J Med Chem"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100130_bib37","doi-asserted-by":"crossref","first-page":"18102","DOI":"10.1021\/acs.jmedchem.1c01504","article-title":"Identification of a hydroxypyrimidinone compound (21) as a potent APJ receptor agonist for the potential treatment of heart failure","volume":"64","author":"Meng","year":"2021","journal-title":"J Med Chem"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100130_bib38","doi-asserted-by":"crossref","first-page":"10456","DOI":"10.1021\/acs.jmedchem.9b01513","article-title":"Biphenyl acid derivatives as APJ receptor agonists","volume":"62","author":"Su","year":"2019","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100130_bib39","doi-asserted-by":"crossref","first-page":"e132898","DOI":"10.1172\/jci.insight.132898","article-title":"Cardiovascular response to small-molecule APJ activation","volume":"5","author":"Ason","year":"2020","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100130_bib40","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41594-022-00797-5","article-title":"Structural insight into apelin receptor-G protein stoichiometry","volume":"29","author":"Yue","year":"2022","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.pharmr.2026.100130_bib41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcp.2016.07.018","article-title":"Cardiac action of the first G protein biased small molecule apelin agonist","volume":"116","author":"Read","year":"2016","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.02.004","article-title":"Structure-based design of non-hypertrophic apelin receptor modulator","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100130_bib43","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2423432122","article-title":"Multiscale biased chemical space remodeling for developing APLNR agonists with anti-HFpEF efficacy","volume":"122","author":"Sun","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib44","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0042-6822(03)00185-5","article-title":"Binding of ALX40-4C to APJ, a CNS-based receptor, inhibits its utilization as a co-receptor by HIV-1","volume":"312","author":"Zhou","year":"2003","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib45","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1096\/fj.201601074R","article-title":"Protamine is an antagonist of apelin receptor, and its activity is reversed by heparin","volume":"31","author":"Le Gonidec","year":"2017","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib46","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/cmdc.201100069","article-title":"Discovery of a competitive apelin receptor (APJ) antagonist","volume":"6","author":"Macaluso","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pharmr.2026.100130_bib47","author":"Davenport"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100130_bib48","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1016\/j.bmcl.2012.08.105","article-title":"Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptor","volume":"22","author":"Maloney","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100130_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202436","article-title":"Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization","volume":"1","author":"McAnally","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2026.100130_bib50","first-page":"A6784","article-title":"Discovery of G-protein biased APJ agonist small molecule for pulmonary diseases [abstract]","volume":"207","author":"Shi","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100130_bib51","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/abbs\/gmu032","article-title":"ELABELA: a novel hormone in cardiac development acting as a new endogenous ligand for the APJ receptor","volume":"46","author":"Xie","year":"2014","journal-title":"Acta Biochim Biophys Sin"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100130_bib52","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1021\/acs.jmedchem.5b01549","article-title":"Discovery and structure-activity relationship of a bioactive fragment of ELABELA that modulates vascular and cardiac functions","volume":"59","author":"Murza","year":"2016","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib53","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1124\/pr.119.017533","article-title":"International Union of Basic and Clinical Pharmacology. CVII. Structure and pharmacology of the apelin receptor with a recommendation that Elabela\/Toddler is a second endogenous peptide ligand","volume":"71","author":"Read","year":"2019","journal-title":"Pharmacol Rev"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100130_bib54","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jacc.2008.06.013","article-title":"Vascular effects of apelin in vivo in man","volume":"52","author":"Japp","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100130_bib55","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/hrt.2009.191122","article-title":"Translational promise of the apelin\u2014APJ system","volume":"96","author":"Barnes","year":"2010","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100130_bib56","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.bcp.2007.12.015","article-title":"The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential","volume":"75","author":"Japp","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100130_bib57","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCULATIONAHA.109.911339","article-title":"Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure","volume":"121","author":"Japp","year":"2010","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib58","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/HYPERTENSIONAHA.116.07057","article-title":"Unlocking the therapeutic potential of apelin","volume":"68","author":"Japp","year":"2016","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib59","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/CIRCHEARTFAILURE.111.000077","article-title":"Sustained cardiovascular actions of APJ agonism during renin-angiotensin system activation and in patients with heart failure","volume":"6","author":"Barnes","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pharmr.2026.100130_bib60","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fnins.2017.00092","article-title":"[Pyr1]apelin-13(1\u201312) is a biologically active ACE2 metabolite of the endogenous cardiovascular peptide [Pyr1]Apelin-13","volume":"11","author":"Yang","year":"2017","journal-title":"Front Neurosci"},{"key":"10.1016\/j.pharmr.2026.100130_bib61","series-title":"Novel Apelin Receptor Ligands in Cardiopulmonary Disease","author":"Brame","year":"2015"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib62","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jacbts.2018.01.013","article-title":"Short-term hemodynamic effects of apelin in patients with pulmonary arterial hypertension","volume":"3","author":"Brash","year":"2018","journal-title":"JACC Basic Transl Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib63","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/dom.13055","article-title":"Apelin administration improves insulin sensitivity in overweight men during hyperinsulinaemic-euglycaemic clamp","volume":"20","author":"Gourdy","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib64","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1161\/HYPERTENSIONAHA.116.08916","article-title":"Beneficial effects of apelin on vascular function in patients with central obesity","volume":"69","author":"Schinzari","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmr.2026.100130_bib65","series-title":"Evaluation of Metabolic and Cardiovascular Actions of [Pyr1]apelin-13 in Patients with Type 2 diabetes mellitus","author":"Sulentic","year":"2022"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib66","doi-asserted-by":"crossref","first-page":"8387","DOI":"10.1038\/s41467-024-52447-7","article-title":"Cardiovascular and renal effects of apelin in chronic kidney disease: a randomised, double-blind, placebo-controlled, crossover study","volume":"15","author":"Chapman","year":"2024","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib68","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10557-022-07328-w","article-title":"A first-in-human study of AMG 986, a Novel Apelin receptor agonist, in healthy subjects and heart failure patients","volume":"37","author":"Winkle","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib69","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40268-022-00388-1","article-title":"Evaluation of the pharmacokinetics and safety of AMG 986 tablet and capsule formulations in healthy adult subjects: a phase I, open-label, randomized study","volume":"22","author":"Trivedi","year":"2022","journal-title":"Drugs R D"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib70","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s40268-022-00386-3","article-title":"A Phase I, open-label, single-dose study to evaluate the pharmacokinetics, safety, and tolerability of AMG 986 in healthy Japanese subjects","volume":"22","author":"Trivedi","year":"2022","journal-title":"Drugs R D"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100130_bib71","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/cpdd.1074","article-title":"A phase 1, open-label study to evaluate the effect of food and concomitant itraconazole administration on the pharmacokinetics of AMG 986 in healthy subjects","volume":"11","author":"Trivedi","year":"2022","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib72","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40268-021-00380-1","article-title":"Effect of severe renal impairment on the safety, tolerability, and pharmacokinetics of AMG 986","volume":"22","author":"Trivedi","year":"2022","journal-title":"Drugs R D"},{"key":"10.1016\/j.pharmr.2026.100130_bib73","author":"Bioage"},{"key":"10.1016\/j.pharmr.2026.100130_bib74","author":"Bioage"},{"key":"10.1016\/j.pharmr.2026.100130_bib75","first-page":"A3775","article-title":"A First-in-human single\/multiple ascending dose study of ANPA-0073, a novel small molecule G-protein biased apelin receptor agonist, in healthy volunteers [abstract]","volume":"207","author":"Bach","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100130_bib76","first-page":"e69","article-title":"First in human study of a novel biased apelin receptor ligand, MM54, A G-alpha (i) agonist\/beta-arrestin antagonist","volume":"123","author":"Davenport","year":"2018","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib77","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/nyas.14123","article-title":"The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders","volume":"1455","author":"Marsault","year":"2019","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmr.2026.100130_bib78","doi-asserted-by":"crossref","first-page":"170697","DOI":"10.1016\/j.peptides.2021.170697","article-title":"Apelin pathway in cardiovascular, kidney, and metabolic diseases: therapeutic role of apelin analogs and apelin receptor agonists","volume":"147","author":"de Oliveira","year":"2022","journal-title":"Peptides"},{"key":"10.1016\/j.pharmr.2026.100130_bib79","doi-asserted-by":"crossref","first-page":"177302","DOI":"10.1016\/j.ejphar.2025.177302","article-title":"Advances in the therapeutic potentials of ligands of the apelin receptor APJ","volume":"991","author":"Wagenaar","year":"2025","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib80","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1042\/CS20240955","article-title":"Metabolically stable apelin analogs: development and functional role in water balance and cardiovascular function","volume":"139","author":"Couvineau","year":"2025","journal-title":"Clin Sci"},{"key":"10.1016\/j.pharmr.2026.100130_bib81","doi-asserted-by":"crossref","first-page":"115268","DOI":"10.1016\/j.biopha.2023.115268","article-title":"Therapeutic potential of apelin and Elabela in cardiovascular disease","volume":"166","author":"Gao","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100130_bib82","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.bbadis.2016.11.007","article-title":"Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases","volume":"1863","author":"Zhong","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100130_bib83","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1042\/CS20200479","article-title":"Interaction between the apelinergic system and ACE2 in the cardiovascular system: therapeutic implications","volume":"134","author":"Chatterjee","year":"2020","journal-title":"Clin Sci"},{"key":"10.1016\/j.pharmr.2026.100130_bib84","doi-asserted-by":"crossref","first-page":"177866","DOI":"10.1016\/j.ejphar.2025.177866","article-title":"Clinical significance of intervention in the renin-angiotensin-aldosterone-apelinergic system","volume":"1003","author":"Wagenaar","year":"2025","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100130_bib85","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.3390\/ijms26072986","article-title":"Apelin\/APJ: another player in the cancer biology network","volume":"26","author":"Naldi","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100130_bib86","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1002\/jcp.30845","article-title":"Roles of apelin\/APJ system in cancer: biomarker, predictor, and emerging therapeutic target","volume":"237","author":"Chen","year":"2022","journal-title":"J Cell Physiol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100130_bib87","doi-asserted-by":"crossref","first-page":"e4116","DOI":"10.1002\/cbf.4116","article-title":"Reciprocal interactions between apelin and noncoding RNAs in cancer progression","volume":"42","author":"Jafarzadeh","year":"2024","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.pharmr.2026.100130_bib88","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fneur.2020.00075","article-title":"The protective effects and mechanisms of Apelin\/APJ system on ischemic stroke: a promising therapeutic target","volume":"11","author":"Tian","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.pharmr.2026.100130_bib89","doi-asserted-by":"crossref","first-page":"104016","DOI":"10.1016\/j.mcn.2025.104016","article-title":"Apelin-13 can regulate adipose-derived mesenchymal stem cells to improve traumatic brain injury","volume":"134","author":"Huang","year":"2025","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.pharmr.2026.100130_bib90","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neuroscience.2024.12.025","article-title":"Effects and mechanisms of Apelin in treating central nervous system diseases","volume":"566","author":"Huang","year":"2025","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib91","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1007\/s11064-023-03869-0","article-title":"Neuroprotective roles of Apelin-13 in neurological diseases","volume":"48","author":"Zhang","year":"2023","journal-title":"Neurochem Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib92","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s11033-022-08075-9","article-title":"Apelin\/APJ system: an emerging therapeutic target for neurological diseases","volume":"50","author":"Li","year":"2023","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.pharmr.2026.100130_bib93","doi-asserted-by":"crossref","first-page":"903151","DOI":"10.3389\/fphar.2022.903151","article-title":"The beneficial roles of apelin-13\/APJ system in cerebral ischemia: pathogenesis and therapeutic strategies","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib94","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11064-021-03448-1","article-title":"Research progress on mechanism of neuroprotective roles of Apelin-13 in prevention and treatment of Alzheimer\u2019s disease","volume":"47","author":"Wan","year":"2022","journal-title":"Neurochem Res"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib95","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s43440-024-00587-4","article-title":"Neuroprotective effect of apelin-13 and other apelin forms-a review","volume":"76","author":"Kami\u0144ska","year":"2024","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharmr.2026.100130_bib96","doi-asserted-by":"crossref","first-page":"148887","DOI":"10.1016\/j.brainres.2024.148887","article-title":"The biological efficacy of Apelin against focal transient cerebral ischemia-reperfusion injury. A systematic review and meta-analysis of animal studies","volume":"1833","author":"Behrouzifar","year":"2024","journal-title":"Brain Res"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100130_bib97","first-page":"7260","article-title":"Research progress of apelin in acute ischemic brain injury","volume":"14","author":"Luo","year":"2022","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.pharmr.2026.100130_bib98","doi-asserted-by":"crossref","first-page":"820002","DOI":"10.3389\/fendo.2022.820002","article-title":"The role of apelin-APJ system in diabetes and obesity","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.pharmr.2026.100130_bib99","doi-asserted-by":"crossref","first-page":"111278","DOI":"10.1016\/j.mce.2021.111278","article-title":"The therapeutic potentials of apelin in obesity-associated diseases","volume":"529","author":"Castan-Laurell","year":"2021","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.pharmr.2026.100130_bib100","doi-asserted-by":"crossref","first-page":"1285788","DOI":"10.3389\/fendo.2023.1285788","article-title":"Beneficial effects of Apelin-13 on metabolic diseases and exercise","volume":"14","author":"Wen","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.pharmr.2026.100130_bib101","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1038\/srep08170","article-title":"Elabela-apelin receptor signaling pathway is functional in mammalian systems","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2026.100130_bib102","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.peptides.2018.09.006","article-title":"Elabela, a newly discovered APJ ligand: similarities and differences with Apelin","volume":"109","author":"Zhang","year":"2018","journal-title":"Peptides"},{"key":"10.1016\/j.pharmr.2026.100130_bib103","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fphys.2020.00181","article-title":"Stretch-induced biased signaling in angiotensin II Type 1 and apelin receptors for the mediation of cardiac contractility and hypertrophy","volume":"11","author":"Seo","year":"2020","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib104","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12079-021-00640-4","article-title":"The network map of Elabela signaling pathway in physiological and pathological conditions","volume":"16","author":"Dagamajalu","year":"2022","journal-title":"J Cell Commun Signal"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12551-023-01044-x","article-title":"Structure-function relationship and physiological role of apelin and its G protein coupled receptor","volume":"15","author":"Murali","year":"2023","journal-title":"Biophys Rev"},{"issue":"42","key":"10.1016\/j.pharmr.2026.100130_bib106","doi-asserted-by":"crossref","first-page":"32627","DOI":"10.1074\/jbc.M110.127167","article-title":"By interacting with the C-terminal Phe of apelin, Phe255 and Trp259 in helix VI of the apelin receptor are critical for internalization","volume":"285","author":"Iturrioz","year":"2010","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib107","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1096\/fj.14-256339","article-title":"New structural insights into the apelin receptor: identification of key residues for apelin binding","volume":"29","author":"Gerbier","year":"2015","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.str.2017.04.008","article-title":"Structural basis for apelin control of the human apelin receptor","volume":"25","author":"Ma","year":"2017","journal-title":"Structure"},{"issue":"D1","key":"10.1016\/j.pharmr.2026.100130_bib109","doi-asserted-by":"crossref","first-page":"D425","DOI":"10.1093\/nar\/gkae1065","article-title":"GPCRdb in 2025: adding odorant receptors, data mapper, structure similarity search and models of physiological ligand complexes","volume":"53","author":"Herrera","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pharmr.2026.100130_bib110","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","article-title":"Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors","volume":"42817","author":"Ballesteros","year":"1995","journal-title":"Methods Neurosci"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100130_bib111","doi-asserted-by":"crossref","first-page":"e14135","DOI":"10.1371\/journal.pone.0014135","article-title":"Biased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanisms","volume":"5","author":"Bonde","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib112","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41589-021-00918-z","article-title":"Identification and mechanism of G protein-biased ligands for chemokine receptor CCR1","volume":"18","author":"Shao","year":"2022","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.pharmr.2026.100130_bib113","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-pharmtox-010919-023545","article-title":"Cryo-electron microscopy: moving beyond X-ray crystal structures for drug receptors and drug development","volume":"60","author":"Garc\u00eda-Nafr\u00eda","year":"2020","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib114","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1021\/acs.jmedchem.0c01547","article-title":"Structure-activity relationship and bioactivity of short analogues of ELABELA as agonists of the apelin receptor","volume":"64","author":"Tr\u00e2n","year":"2021","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1124\/pharmrev.120.000011","article-title":"Mutations in G protein-coupled receptors: mechanisms, pathophysiology and potential therapeutic approaches","volume":"73","author":"Sch\u00f6neberg","year":"2021","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib116","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.devcel.2007.01.011","article-title":"Apelin and its receptor control heart field formation during zebrafish gastrulation","volume":"12","author":"Zeng","year":"2007","journal-title":"Dev Cell"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib117","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.devcel.2007.01.012","article-title":"The g protein-coupled receptor agtrl1b regulates early development of myocardial progenitors","volume":"12","author":"Scott","year":"2007","journal-title":"Dev Cell"},{"key":"10.1016\/j.pharmr.2026.100130_bib118","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.fob.2013.08.001","article-title":"Preferential apelin-13 production by the proprotein convertase PCSK3 is implicated in obesity","volume":"3","author":"Shin","year":"2013","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.pharmr.2026.100130_bib119","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejmech.2019.01.040","article-title":"Plasma kallikrein cleaves and inactivates apelin-17: palmitoyl- and PEG-extended apelin-17 analogs as metabolically stable blood pressure-lowering agents","volume":"166","author":"Fischer","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/bip.22498","article-title":"Marsault \u00c9. Stability and degradation patterns of chemically modified analogs of apelin-13 in plasma and cerebrospinal fluid","volume":"102","author":"Murza","year":"2014","journal-title":"Biopolymers"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100130_bib121","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib122","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/HYPERTENSIONAHA.115.06892","article-title":"Angiotensin-converting enzyme 2 metabolizes and partially inactivates Pyr-Apelin-13 and Apelin-17: physiological effects in the cardiovascular system","volume":"68","author":"Wang","year":"2016","journal-title":"Hypertension"},{"issue":"28","key":"10.1016\/j.pharmr.2026.100130_bib123","doi-asserted-by":"crossref","first-page":"10464","DOI":"10.1073\/pnas.0403518101","article-title":"Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release","volume":"101","author":"De Mota","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2013.07.006","article-title":"Pyroglutamyl apelin-13 identified as the major apelin isoform in human plasma","volume":"442","author":"Zhen","year":"2013","journal-title":"Anal Biochem"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100130_bib125","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1021\/pr200725x","article-title":"Identification and characterization of apelin peptides in bovine colostrum and milk by liquid chromatography-mass spectrometry","volume":"10","author":"Mesmin","year":"2011","journal-title":"J Proteome Res"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100130_bib126","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.bbagen.2017.05.017","article-title":"Bioactivity of the putative apelin proprotein expands the repertoire of apelin receptor ligands","volume":"1861","author":"Shin","year":"2017","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib127","doi-asserted-by":"crossref","first-page":"19934","DOI":"10.1038\/s41598-019-56157-9","article-title":"Development and validation of an LC-MS\/MS method for detection and quantification of in vivo derived metabolites of [Pyr1]apelin-13 in humans","volume":"9","author":"Nyimanu","year":"2019","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100130_bib128","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1476-5381.2010.00821.x","article-title":"Modulation of the apelin\/APJ system in heart failure and atherosclerosis in man","volume":"160","author":"Pitkin","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100130_bib129","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1111\/bcp.15446","article-title":"Apelin is expressed throughout the human kidney, is elevated in chronic kidney disease & associates independently with decline in kidney function","volume":"88","author":"Nyimanu","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib130","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/bph.14953","article-title":"Fluorescent ligands: bringing light to emerging GPCR paradigms","volume":"177","author":"Soave","year":"2020","journal-title":"Br J Pharmacol"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100130_bib131","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1111\/bph.13316","article-title":"Fluorescence- and bioluminescence-based approaches to study GPCR ligand binding","volume":"173","author":"Stoddart","year":"2016","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib132","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/bph.12265","article-title":"The evolving small-molecule fluorescent-conjugate toolbox for Class A GPCRs","volume":"171","author":"Vernall","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"1 Pt A","key":"10.1016\/j.pharmr.2026.100130_bib133","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbamem.2013.09.005","article-title":"Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors","volume":"1838","author":"Sridharan","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib134","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/chem.201503630","article-title":"Convenient access to fluorescent probes by chemoselective acylation of Hydrazinopeptides: application to the synthesis of the first Far-red ligand for apelin receptor imaging","volume":"22","author":"Margathe","year":"2016","journal-title":"Chemistry"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib135","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1021\/acs.bioconjchem.2c00500","article-title":"Rapid and highly selective fluorescent labeling of peptides via a Thia-Diels-Alder cycloaddition: application to apelin","volume":"34","author":"Maujean","year":"2023","journal-title":"Bioconjug Chem"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib136","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.stem.2015.08.010","article-title":"ELABELA is an endogenous growth factor that sustains hESC self-renewal via the PI3K\/AKT pathway","volume":"17","author":"Ho","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib137","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0006-291X(03)01424-4","article-title":"Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure","volume":"308","author":"F\u00f6ldes","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100130_bib138","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/01.CIR.0000091235.94914.75","article-title":"Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction","volume":"108","author":"Chen","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib139","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejheart.2006.06.005","article-title":"Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin","volume":"9","author":"Francia","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pharmr.2026.100130_bib140","doi-asserted-by":"crossref","first-page":"742601","DOI":"10.3389\/fcvm.2021.742601","article-title":"Association between apelin and atrial fibrillation in patients with high risk of ischemic stroke","volume":"8","author":"Bohm","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.pharmr.2026.100130_bib141","doi-asserted-by":"crossref","first-page":"986295","DOI":"10.3389\/fphys.2022.986295","article-title":"Apelin-17 to diagnose idiopathic pulmonary arterial hypertension: a biomarker study","volume":"13","author":"Foris","year":"2022","journal-title":"Front Physiol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib142","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/ATVBAHA.110.219980","article-title":"Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertension","volume":"31","author":"Chandra","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1\u20133","key":"10.1016\/j.pharmr.2026.100130_bib143","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.regpep.2005.09.032","article-title":"Apelin: a new plasma marker of cardiopulmonary disease","volume":"133","author":"Goetze","year":"2006","journal-title":"Regul Pept"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100130_bib144","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.21037\/jtd-21-1728","article-title":"ELABELA acts as a protective biomarker in patients with atrial fibrillation","volume":"13","author":"Cui","year":"2021","journal-title":"J Thorac Dis"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib145","doi-asserted-by":"crossref","first-page":"11333","DOI":"10.1038\/s41598-024-61480-x","article-title":"Decreased plasma ELABELA level as a novel screening indicator for heart failure: a cohort and observational study","volume":"14","author":"Liu","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib146","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12872-021-02197-x","article-title":"Declined ELABELA plasma levels in hypertension patients with atrial fibrillation: a case control study","volume":"21","author":"Ma","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib147","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000092122","article-title":"Apelin and cardiac function in hemodialyzed patients: possible relations?","volume":"26","author":"Ma\u0142yszko","year":"2006","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib148","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/0886022X.2012.668490","article-title":"Apelin: a peptide involved in cardiovascular risk in hemodialysis patients?","volume":"34","author":"Leal","year":"2012","journal-title":"Ren Fail"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100130_bib149","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1016\/j.transproceed.2008.06.059","article-title":"Apelin, a novel adipocytokine, in relation to endothelial function and inflammation in kidney allograft recipients","volume":"40","author":"Malyszko","year":"2008","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib150","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pharmthera.2005.04.001","article-title":"Emerging roles of apelin in biology and medicine","volume":"107","author":"Kleinz","year":"2005","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib151","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/1744-9987.12613","article-title":"Relation of serum ADMA, Apelin-13 and LOX-1 levels with inflammatory and echocardiographic parameters in hemodialysis patients","volume":"22","author":"Dogan","year":"2018","journal-title":"Ther Apher Dial"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib152","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/1744-9987.12412","article-title":"Evaluation of fibrosis markers: apelin and transforming growth factor-\u03b21 in autosomal dominant polycystic kidney disease patients","volume":"20","author":"Kocer","year":"2016","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.pharmr.2026.100130_bib153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.peptides.2013.08.007","article-title":"Apelin and copeptin: two opposite biomarkers associated with kidney function decline and cyst growth in autosomal dominant polycystic kidney disease","volume":"49","author":"Lacquaniti","year":"2013","journal-title":"Peptides"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100130_bib154","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.3390\/ijms22136885","article-title":"Coregulation analysis of mechanistic biomarkers in autosomal dominant polycystic kidney disease","volume":"22","author":"Leierer","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib155","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.advms.2020.02.002","article-title":"Role of Apelin\/APJ axis in cancer development and progression","volume":"65","author":"Masoumi","year":"2020","journal-title":"Adv Med Sci"},{"issue":"19","key":"10.1016\/j.pharmr.2026.100130_bib156","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.3390\/cancers14194656","article-title":"Apelin, a circulating biomarker in cancer evaluation: a systematic review","volume":"14","author":"Grinstead","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib157","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1186\/s12885-016-2815-y","article-title":"Tumor apelin, not serum apelin, is associated with the clinical features and prognosis of gastric cancer","volume":"16","author":"Feng","year":"2016","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib158","doi-asserted-by":"crossref","first-page":"20441","DOI":"10.1038\/s41598-024-71495-z","article-title":"Apelin (APLN) is a biomarker contributing to the diagnosis and prognosis of hepatocellular carcinoma","volume":"14","author":"Mao","year":"2024","journal-title":"Sci Rep"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100130_bib159","doi-asserted-by":"crossref","first-page":"e70152","DOI":"10.1111\/jcmm.70152","article-title":"Single-cell and spatial transcriptomics reveal apelin\/APJ pathway\u2019s role in microvessel formation and tumour progression in hepatocellular carcinoma","volume":"28","author":"Zhu","year":"2024","journal-title":"J Cell Mol Med"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100130_bib160","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.7150\/thno.34713","article-title":"APLN promotes hepatocellular carcinoma through activating PI3K\/Akt pathway and is a druggable target","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100130_bib161","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.ajpath.2018.04.008","article-title":"ELABELA\/APELA levels are not decreased in the maternal circulation or placenta among women with preeclampsia","volume":"188","author":"Pritchard","year":"2018","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib162","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ajog.2018.12.020","article-title":"ELABELA concentration is not decreased in maternal plasma before the onset of preeclampsia","volume":"220","author":"Villie","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100130_bib163","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/01443615.2019.1572727","article-title":"Evaluation of elabela, apelin and nitric oxide findings in maternal blood of normal pregnant women, pregnant women with pre-eclampsia, severe pre-eclampsia and umbilical arteries and venules of newborns","volume":"39","author":"Deniz","year":"2019","journal-title":"J Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib164","doi-asserted-by":"crossref","first-page":"E773","DOI":"10.1152\/ajpendo.00383.2018","article-title":"ELABELA, as a potential diagnostic biomarker of preeclampsia, regulates abnormally shallow placentation via APJ","volume":"316","author":"Zhou","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib165","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/14767058.2018.1484089","article-title":"ELABELA plasma concentrations are increased in women with late-onset preeclampsia","volume":"33","author":"Panaitescu","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib166","doi-asserted-by":"crossref","first-page":"19077","DOI":"10.1038\/s41598-019-55650-5","article-title":"Peptide hormone ELABELA enhances extravillous trophoblast differentiation, but placenta is not the major source of circulating ELABELA in pregnancy","volume":"9","author":"Georgiadou","year":"2019","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100130_bib167","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1080\/09513590.2022.2122433","article-title":"Systematic review and meta-analysis regarding maternal apelin in pregnant women with and without preeclampsia","volume":"38","author":"Fuentes-Carrasco","year":"2022","journal-title":"Gynecol Endocrinol"},{"issue":"6352","key":"10.1016\/j.pharmr.2026.100130_bib168","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.aam6607","article-title":"ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice","volume":"357","author":"Ho","year":"2017","journal-title":"Science"},{"issue":"25","key":"10.1016\/j.pharmr.2026.100130_bib169","doi-asserted-by":"crossref","first-page":"26274","DOI":"10.1074\/jbc.M404149200","article-title":"Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo","volume":"279","author":"Ishida","year":"2004","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib170","doi-asserted-by":"crossref","first-page":"H1904","DOI":"10.1152\/ajpheart.00686.2009","article-title":"Endogenous regulation of cardiovascular function by apelin-APJ","volume":"297","author":"Charo","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib171","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/CIRCRESAHA.113.301324","article-title":"Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development","volume":"113","author":"Kang","year":"2013","journal-title":"Circ Res"},{"issue":"7411","key":"10.1016\/j.pharmr.2026.100130_bib172","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature11263","article-title":"APJ acts as a dual receptor in cardiac hypertrophy","volume":"488","author":"Scimia","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib173","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/sj.emboj.7601982","article-title":"Spatial and temporal role of the apelin\/APJ system in the caliber size regulation of blood vessels during angiogenesis","volume":"27","author":"Kidoya","year":"2008","journal-title":"EMBO J"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib174","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/CIRCRESAHA.107.158659","article-title":"Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload","volume":"101","author":"Kuba","year":"2007","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100130_bib175","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.celrep.2017.08.014","article-title":"Loss of Apela peptide in mice causes low penetrance embryonic lethality and defects in early mesodermal derivatives","volume":"20","author":"Freyer","year":"2017","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib176","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1160\/TH08-06-0358","article-title":"Maturation of blood vessels by haematopoietic stem cells and progenitor cells: involvement of apelin\/APJ and angiopoietin\/Tie2 interactions in vessel caliber size regulation","volume":"101","author":"Takakura","year":"2009","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib177","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1161\/CIRCRESAHA.109.201186","article-title":"G protein-coupled receptor APJ and its ligand apelin act downstream of Cripto to specify embryonic stem cells toward the cardiac lineage through extracellular signal-regulated kinase\/p70S6 kinase signaling pathway","volume":"105","author":"D\u2019Aniello","year":"2009","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib178","doi-asserted-by":"crossref","first-page":"e38328","DOI":"10.1371\/journal.pone.0038328","article-title":"Apelin enhances directed cardiac differentiation of mouse and human embryonic stem cells","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib179","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.scr.2011.12.004","article-title":"Protective effect of apelin on cultured rat bone marrow mesenchymal stem cells against apoptosis","volume":"8","author":"Zeng","year":"2012","journal-title":"Stem Cell Res"},{"issue":"26","key":"10.1016\/j.pharmr.2026.100130_bib180","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1182\/blood-2011-12-396093","article-title":"APELIN promotes hematopoiesis from human embryonic stem cells","volume":"119","author":"Yu","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib181","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.stem.2015.04.002","article-title":"An Apela RNA-containing negative feedback loop regulates p53-mediated apoptosis in embryonic stem cells","volume":"16","author":"Li","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib182","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.scr.2015.08.009","article-title":"OP9-Lhx2 stromal cells facilitate derivation of hematopoietic progenitors both in vitro and in vivo","volume":"15","author":"Chen","year":"2015","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.pharmr.2026.100130_bib183","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.biomaterials.2015.10.062","article-title":"Neoangiogenesis of human mesenchymal stem cells transfected with peptide-loaded and gene-coated PLGA nanoparticles","volume":"76","author":"Park","year":"2016","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100130_bib184","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3727\/096368916X691123","article-title":"Activation of endogenous cardiac stem cells by Apelin-13 in infarcted rat heart","volume":"25","author":"Zhang","year":"2016","journal-title":"Cell Transplant"},{"key":"10.1016\/j.pharmr.2026.100130_bib185","doi-asserted-by":"crossref","first-page":"21914","DOI":"10.1038\/srep21914","article-title":"Therapeutic efficacy of apelin on transplanted mesenchymal stem cells in hindlimb ischemic mice via regulation of autophagy","volume":"6","author":"Liang","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib186","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/cbin.10581","article-title":"Apelin: an endogenous peptide essential for cardiomyogenic differentiation of mesenchymal stem cells via activating extracellular signal-regulated kinase 1\/2 and 5","volume":"40","author":"Wang","year":"2016","journal-title":"Cell Biol Int"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib187","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.yexmp.2017.01.015","article-title":"Apelin promotes mesenchymal stem cells survival and vascularization under hypoxic-ischemic condition in vitro involving the upregulation of vascular endothelial growth factor","volume":"102","author":"Hou","year":"2017","journal-title":"Exp Mol Pathol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib188","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1161\/CIRCRESAHA.118.312913","article-title":"Large-scale single-cell RNA-Seq reveals molecular signatures of heterogeneous populations of human induced pluripotent stem cell-derived endothelial cells","volume":"123","author":"Paik","year":"2018","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib189","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s13287-018-1084-x","article-title":"Overexpression of apelin in Wharton\u2019 jelly mesenchymal stem cell reverses insulin resistance and promotes pancreatic beta cell proliferation in type 2 diabetic rats","volume":"9","author":"Gao","year":"2018","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib190","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13287-019-1286-x","article-title":"Apelin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells partly through Wnt\/beta-catenin signaling pathway","volume":"10","author":"Hang","year":"2019","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib191","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.stem.2019.10.006","article-title":"Apelin+ endothelial niche cells control hematopoiesis and mediate vascular regeneration after myeloablative injury","volume":"25","author":"Chen","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.pharmr.2026.100130_bib192","doi-asserted-by":"crossref","first-page":"106886","DOI":"10.1016\/j.vascn.2020.106886","article-title":"Inotropic assessment in engineered 3D cardiac tissues using human induced pluripotent stem cell-derived cardiomyocytes in the Biowire(TM) II platform","volume":"105","author":"Qu","year":"2020","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib193","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1186\/s13287-020-02063-1","article-title":"ELABELA ameliorates hypoxic\/ischemic-induced bone mesenchymal stem cell apoptosis via alleviation of mitochondrial dysfunction and activation of PI3K\/AKT and ERK1\/2 pathways","volume":"11","author":"Fu","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.pharmr.2026.100130_bib194","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.freeradbiomed.2020.12.235","article-title":"Apelin-13 induces mitophagy in bone marrow mesenchymal stem cells to suppress intracellular oxidative stress and ameliorate osteoporosis by activation of AMPK signaling pathway","volume":"163","author":"Chen","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmr.2026.100130_bib195","doi-asserted-by":"crossref","first-page":"628463","DOI":"10.3389\/fcell.2021.628463","article-title":"Apelin rejuvenates aged human mesenchymal stem cells by regulating autophagy and improves cardiac protection after infarction","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib196","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.stemcr.2021.02.003","article-title":"Modulation of APLNR signaling is required during the development and maintenance of the hematopoietic system","volume":"16","author":"Jackson","year":"2021","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.pharmr.2026.100130_bib197","doi-asserted-by":"crossref","first-page":"3742678","DOI":"10.1155\/2022\/3742678","article-title":"Apelin-13 pretreatment promotes the cardioprotective effect of mesenchymal stem cells against myocardial infarction by improving their survival","volume":"2022","author":"Chen","year":"2022","journal-title":"Stem Cells Int"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib198","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12974-022-02518-7","article-title":"Apelin alleviated neuroinflammation and promoted endogenous neural stem cell proliferation and differentiation after spinal cord injury in rats","volume":"19","author":"Liu","year":"2022","journal-title":"J Neuroinflammation"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib199","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s13577-023-00861-2","article-title":"Regulatory role of apelin receptor signaling in migration and differentiation of mouse embryonic stem cell-derived mesoderm cells and mesenchymal stem\/stromal cells","volume":"36","author":"\u015ei\u015fli","year":"2023","journal-title":"Hum Cell"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib200","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/cvr\/cvac065","article-title":"Inducible apelin receptor knockdown reduces differentiation efficiency and contractility of hESC-derived cardiomyocytes","volume":"119","author":"Macrae","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"17\u201318","key":"10.1016\/j.pharmr.2026.100130_bib201","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1089\/scd.2023.0008","article-title":"Apelin-overexpressing neural stem cells in conjunction with a silk fibroin nanofiber scaffold for the treatment of traumatic brain injury","volume":"32","author":"Li","year":"2023","journal-title":"Stem Cells Dev"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib202","doi-asserted-by":"crossref","first-page":"e2300217","DOI":"10.1002\/adbi.202300217","article-title":"The role of Aplnr signaling in the developmental regulation of mesenchymal stem cell differentiation from human pluripotent stem cells","volume":"8","author":"\u015ei\u015fli","year":"2024","journal-title":"Adv Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib203","doi-asserted-by":"crossref","first-page":"111","DOI":"10.32607\/actanaturae.17863","article-title":"ELABELA-APJ axis enhances mesenchymal stem cell proliferation and migration via the METTL3\/PI3K\/AKT pathway","volume":"16","author":"Xu","year":"2024","journal-title":"Acta Nat"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib204","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12902-023-01535-8","article-title":"Effects of conditioned media derived from human Wharton\u2019s jelly mesenchymal stem cells on diabetic nephropathy and hepatopathy via modulating TGF-beta and apelin signaling pathways in male rats","volume":"24","author":"Karimi","year":"2024","journal-title":"BMC Endocr Disord"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100130_bib205","doi-asserted-by":"crossref","first-page":"9621","DOI":"10.3390\/ijms25179621","article-title":"Inflammatory intracellular signaling in neurons is influenced by glial soluble factors in iPSC-based cell model of PARK2-associated Parkinson\u2019s disease","volume":"25","author":"Gerasimova","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2026.100130_bib206","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2147\/IJN.S498770","article-title":"Exosomes derived from apelin-pretreated mesenchymal stem cells ameliorate sepsis-induced myocardial dysfunction by alleviating cardiomyocyte pyroptosis via delivery of miR-34a-5p","volume":"20","author":"Li","year":"2025","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib207","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.devcel.2007.02.005","article-title":"Apelin and its G protein-coupled receptor regulate cardiac development as well as cardiac function","volume":"12","author":"Quertermous","year":"2007","journal-title":"Dev Cell"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib208","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.devcel.2015.02.024","article-title":"APJ regulates parallel alignment of arteries and veins in the skin","volume":"33","author":"Kidoya","year":"2015","journal-title":"Dev Cell"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib209","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/1087057113475480","article-title":"Screening beta-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors","volume":"18","author":"Southern","year":"2013","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.pharmr.2026.100130_bib210","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.13758","article-title":"The apelin receptor enhances Nodal\/TGFbeta signaling to ensure proper cardiac development","volume":"5","author":"Deshwar","year":"2016","journal-title":"eLife"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib211","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0304-3940(96)13198-0","article-title":"Low stringency hybridization study of the dopamine D4 receptor revealed D4-like mRNA distribution of the orphan seven-transmembrane receptor, APJ, in human brain","volume":"219","author":"Matsumoto","year":"1996","journal-title":"Neurosci Lett"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100130_bib212","doi-asserted-by":"crossref","first-page":"7934","DOI":"10.1128\/JVI.72.10.7934-7940.1998","article-title":"An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus","volume":"72","author":"Edinger","year":"1998","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib213","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.peptides.2011.12.005","article-title":"Central and peripheral apelin receptor distribution in the mouse: species differences with rat","volume":"33","author":"Pope","year":"2012","journal-title":"Peptides"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib214","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.regpep.2004.10.019","article-title":"Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells","volume":"126","author":"Kleinz","year":"2005","journal-title":"Regul Pept"},{"issue":"6220","key":"10.1016\/j.pharmr.2026.100130_bib215","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"issue":"31","key":"10.1016\/j.pharmr.2026.100130_bib216","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh2169","article-title":"A single-cell type transcriptomics map of human tissues","volume":"7","author":"Karlsson","year":"2021","journal-title":"Sci Adv"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100130_bib217","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41591-018-0131-6","article-title":"The exerkine apelin reverses age-associated sarcopenia","volume":"24","author":"Vinel","year":"2018","journal-title":"Nat Med"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100130_bib218","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/cvr\/cvad171","article-title":"Targeting the apelin system for the treatment of cardiovascular diseases","volume":"119","author":"Chapman","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib219","doi-asserted-by":"crossref","first-page":"E1161","DOI":"10.1152\/ajpendo.00598.2009","article-title":"Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans","volume":"298","author":"Dray","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1\u20133","key":"10.1016\/j.pharmr.2026.100130_bib220","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.regpep.2010.03.005","article-title":"Apelin is a novel islet peptide","volume":"162","author":"Ringstr\u00f6m","year":"2010","journal-title":"Regul Pept"},{"key":"10.1016\/j.pharmr.2026.100130_bib221","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.canlet.2016.11.025","article-title":"Inhibition of the apelin\/apelin receptor axis decreases cholangiocarcinoma growth","volume":"386","author":"Hall","year":"2017","journal-title":"Cancer Lett"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib222","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.21873\/anticanres.13435","article-title":"Prognostic role of apelin receptor expression in hepatocellular carcinoma treated with curative surgical resection","volume":"39","author":"Lee","year":"2019","journal-title":"Anticancer Res"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100130_bib223","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1093\/brain\/awx253","article-title":"Pharmacological targeting of apelin impairs glioblastoma growth","volume":"140","author":"Harford-Wright","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.pharmr.2026.100130_bib224","doi-asserted-by":"crossref","first-page":"1379658","DOI":"10.3389\/fnins.2024.1379658","article-title":"Expression of the apelin receptor, a novel potential therapeutic target, and its endogenous ligands in diverse stem cell populations in human glioblastoma","volume":"18","author":"Williams","year":"2024","journal-title":"Front Neurosci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib225","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.regpep.2003.11.002","article-title":"Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells","volume":"118","author":"Kleinz","year":"2004","journal-title":"Regul Pept"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib226","first-page":"644","article-title":"Apelin and its receptor APJ in human aortic valve stenosis","volume":"18","author":"Peltonen","year":"2009","journal-title":"J Heart Valve Dis"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib227","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00383-012-3210-7","article-title":"Apelin is a marker of the progression of liver fibrosis and portal hypertension in patients with biliary atresia","volume":"29","author":"Chen","year":"2013","journal-title":"Pediatr Surg Int"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib228","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10735-007-9135-0","article-title":"Immunohistochemical localization of apelin in human normal breast and breast carcinoma","volume":"39","author":"Wang","year":"2008","journal-title":"J Mol Histol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib229","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.regpep.2007.02.002","article-title":"Increased colonic apelin production in rodents with experimental colitis and in humans with IBD","volume":"142","author":"Han","year":"2007","journal-title":"Regul Pept"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib230","first-page":"691","article-title":"Apelin and apelin receptor in human placenta: expression, signalling pathway and regulation of trophoblast JEG-3 and BeWo cells proliferation and cell cycle","volume":"45","author":"Mlyczy\u0144ska","year":"2020","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.pharmr.2026.100130_bib231","doi-asserted-by":"crossref","first-page":"170642","DOI":"10.1016\/j.peptides.2021.170642","article-title":"In vitro metabolism of synthetic Elabela\/Toddler (ELA-32) peptide in human plasma and kidney homogenates analyzed with mass spectrometry and validation of endogenous peptide quantification in tissues by ELISA","volume":"145","author":"Nyimanu","year":"2021","journal-title":"Peptides"},{"key":"10.1016\/j.pharmr.2026.100130_bib232","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-61779-909-9_9","article-title":"Measurements of beta-arrestin recruitment to activated seven transmembrane receptors using enzyme complementation","volume":"897","author":"Bassoni","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.pharmr.2026.100130_bib233","doi-asserted-by":"crossref","first-page":"1369489","DOI":"10.3389\/fphar.2024.1369489","article-title":"The biased apelin receptor agonist, MM07, reverses Sugen\/hypoxia-induced pulmonary arterial hypertension as effectively as the endothelin antagonist macitentan","volume":"15","author":"Williams","year":"2024","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib234","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cmet.2008.10.003","article-title":"Apelin stimulates glucose utilization in normal and obese insulin-resistant mice","volume":"8","author":"Dray","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmr.2026.100130_bib235","doi-asserted-by":"crossref","first-page":"823193","DOI":"10.1155\/2012\/823193","article-title":"Targeting the ACE2 and apelin pathways are novel therapies for heart failure: opportunities and challenges","volume":"2012","author":"Kazemi-Bajestani","year":"2012","journal-title":"Cardiol Res Pract"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib236","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41573-020-0062-z","article-title":"Advances in therapeutic peptides targeting G protein-coupled receptors","volume":"19","author":"Davenport","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib237","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000054609","article-title":"Cloning, pharmacological characterization and brain distribution of the rat apelin receptor","volume":"72","author":"De Mota","year":"2000","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib238","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1210\/en.2004-0359","article-title":"Modification of the terminal residue of apelin-13 antagonizes its hypotensive action","volume":"146","author":"Lee","year":"2005","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib239","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1021\/acs.jmedchem.7b01353","article-title":"A systematic exploration of macrocyclization in Apelin-13: impact on binding, signaling, stability, and cardiovascular effects","volume":"61","author":"Tr\u00e2n","year":"2018","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib240","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1096\/fj.201600784R","article-title":"Development of original metabolically stable apelin-17 analogs with diuretic and cardiovascular effects","volume":"31","author":"Gerbier","year":"2017","journal-title":"FASEB J"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib241","first-page":"911","article-title":"The metabolically resistant Apelin-17 analogue LIT01-196 reduces cardiac dysfunction and remodelling in heart failure after myocardial infarction","volume":"41","author":"Girault-Sotias","year":"2025","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib242","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.peptides.2012.09.003","article-title":"Cardiovascular effects of a pegylated apelin","volume":"38","author":"Jia","year":"2012","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib243","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1074\/jbc.M116.748103","article-title":"Apelin-36 modulates blood glucose and body weight independently of canonical APJ receptor signaling","volume":"292","author":"Galon-Tilleman","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2026.100130_bib244","doi-asserted-by":"crossref","first-page":"170139","DOI":"10.1016\/j.peptides.2019.170139","article-title":"Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor","volume":"121","author":"Nyimanu","year":"2019","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib245","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s42003-020-0867-7","article-title":"Function-based high-throughput screening for antibody antagonists and agonists against G protein-coupled receptors","volume":"3","author":"Ren","year":"2020","journal-title":"Commun Biol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib246","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1046\/j.1471-4159.2001.00320.x","article-title":"Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain","volume":"77","author":"Reaux","year":"2001","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib247","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1471-4159.2001.00269.x","article-title":"Visualizing differences in ligand-induced beta-arrestin-GFP interactions and trafficking between three recently characterized G protein-coupled receptors","volume":"77","author":"Evans","year":"2001","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib248","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/sja.sja_510_21","article-title":"Oliceridine- opioid of the 21st century","volume":"16","author":"Goudra","year":"2022","journal-title":"Saudi J Anaesth"},{"issue":"35","key":"10.1016\/j.pharmr.2026.100130_bib249","doi-asserted-by":"crossref","first-page":"24599","DOI":"10.1074\/jbc.M113.541698","article-title":"Biased signaling favoring gi over beta-arrestin promoted by an apelin fragment lacking the C-terminal phenylalanine","volume":"289","author":"Ceraudo","year":"2014","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib250","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1039\/C6OB02247B","article-title":"Structure-activity relationship of novel macrocyclic biased apelin receptor agonists","volume":"15","author":"Murza","year":"2017","journal-title":"Org Biomol Chem"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib251","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1021\/acsptsci.2c00219","article-title":"Signaling modulation via minimal C-terminal modifications of Apelin-13","volume":"6","author":"Th\u00e9roux","year":"2023","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100130_bib252","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/art.40533","article-title":"Inhibitory regulation of skin fibrosis in systemic sclerosis by Apelin\/APJ signaling","volume":"70","author":"Yokoyama","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100130_bib253","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/bph.14603","article-title":"A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertension","volume":"176","author":"Yang","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100130_bib254","doi-asserted-by":"crossref","first-page":"588669","DOI":"10.3389\/fphar.2020.588669","article-title":"The G protein biased small molecule apelin agonist CMF-019 is disease modifying in endothelial cell apoptosis in vitro and induces vasodilatation without desensitisation in vivo","volume":"11","author":"Read","year":"2021","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100130_bib255","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1021\/jm401789v","article-title":"Structure-activity relationship studies toward the discovery of selective apelin receptor agonists","volume":"57","author":"Margathe","year":"2014","journal-title":"J Med Chem"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100130_bib256","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1016\/j.bmc.2016.06.018","article-title":"Discovery of a novel small molecule agonist scaffold for the APJ receptor","volume":"24","author":"Narayanan","year":"2016","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib257","doi-asserted-by":"crossref","first-page":"115237","DOI":"10.1016\/j.bmc.2019.115237","article-title":"Identification of potent pyrazole based APELIN receptor (APJ) agonists","volume":"28","author":"Narayanan","year":"2020","journal-title":"Bioorg Med Chem"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100130_bib258","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/s41587-022-01457-1","article-title":"Machine learning powers biobank-driven drug discovery","volume":"40","author":"Eisenstein","year":"2022","journal-title":"Nat Biotechnol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib259","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41587-024-02176-5","article-title":"After obesity drugs\u2019 success, companies rush to preserve skeletal muscle","volume":"42","author":"Arnold","year":"2024","journal-title":"Nat Biotechnol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib260","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/13813455.2018.1453521","article-title":"Interactive effects of apelin, renin-angiotensin system and nitric oxide in treatment of obesity-induced type 2 diabetes mellitus in male albino rats","volume":"125","author":"Sabry","year":"2019","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.pharmr.2026.100130_bib261","author":"Hachtel"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib262","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/FJC.0000000000001671","article-title":"Activation of APJ receptors by CMF-019, but not apelin, causes endothelium-dependent relaxation of spontaneously hypertensive rat coronary arteries","volume":"85","author":"Anto","year":"2025","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100130_bib263","author":"Lim"},{"key":"10.1016\/j.pharmr.2026.100130_bib264","series-title":"Imaging Glioblastoma Metabolism Using Mass Spectrometry Imaging","author":"Tsyben","year":"2023"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100130_bib265","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.tips.2015.06.002","article-title":"Apelin, Elabela\/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system","volume":"36","author":"Yang","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmr.2026.100130_bib266","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.peptides.2018.04.011","article-title":"Apelin and Elabela\/Toddler; double ligands for APJ\/Apelin receptor in heart development, physiology, and pathology","volume":"111","author":"Kuba","year":"2019","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib267","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nm.3040","article-title":"An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension","volume":"19","author":"Kim","year":"2013","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100130_bib268","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1172\/JCI43382","article-title":"Disruption of PPAR\u03b3\/\u03b2-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival","volume":"121","author":"Alastalo","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmr.2026.100130_bib269","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.hrtlng.2023.01.008","article-title":"Reduced Apela\/APJ system expression in patients with pulmonary artery hypertension secondary to chronic obstructive pulmonary disease","volume":"59","author":"Hu","year":"2023","journal-title":"Heart Lung"},{"key":"10.1016\/j.pharmr.2026.100130_bib270","doi-asserted-by":"crossref","first-page":"170440","DOI":"10.1016\/j.peptides.2020.170440","article-title":"Plasma levels of apelin are reduced in patients with liver fibrosis and cirrhosis but are not correlated with circulating levels of bone morphogenetic protein 9 and 10","volume":"136","author":"Owen","year":"2021","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib271","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.advms.2023.09.001","article-title":"The profile of adipokines associated with fibrosis and impaired microcirculation in systemic sclerosis","volume":"68","author":"Niemczyk","year":"2023","journal-title":"Adv Med Sci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib272","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1556\/2060.2023.00264","article-title":"Circulating apelin, IL22RA2 and VEGF in pre-capillary pulmonary hypertension","volume":"110","author":"Cs\u00f3sza","year":"2023","journal-title":"Physiol Int"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100130_bib273","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1161\/ATVBAHA.123.320005","article-title":"Molecular changes implicate angiogenesis and arterial remodeling in systemic sclerosis-associated and idiopathic pulmonary hypertension","volume":"44","author":"Zhou","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7831","key":"10.1016\/j.pharmr.2026.100130_bib274","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41586-020-2822-7","article-title":"Capillary cell-type specialization in the alveolus","volume":"586","author":"Gillich","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib275","doi-asserted-by":"crossref","first-page":"H2007","DOI":"10.1152\/ajpheart.00089.2009","article-title":"Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension","volume":"296","author":"Falc\u00e3o-Pires","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib276","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1165\/rcmb.2010-0412OC","article-title":"Molecular signature of a right heart failure program in chronic severe pulmonary hypertension","volume":"45","author":"Drake","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100130_bib277","doi-asserted-by":"crossref","first-page":"L873","DOI":"10.1152\/ajplung.00006.2015","article-title":"Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones","volume":"308","author":"Frump","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"19","key":"10.1016\/j.pharmr.2026.100130_bib278","doi-asserted-by":"crossref","first-page":"e13438","DOI":"10.14814\/phy2.13438","article-title":"Isolated heart model demonstrates evidence of contractile and diastolic dysfunction in right ventricles from rats with sugen\/hypoxia-induced pulmonary hypertension","volume":"5","author":"Neto-Neves","year":"2017","journal-title":"Physiol Rep"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib279","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/CIRCRESAHA.118.313356","article-title":"Selective BMP-9 inhibition partially protects against experimental pulmonary hypertension","volume":"124","author":"Tu","year":"2019","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib280","doi-asserted-by":"crossref","first-page":"e129433","DOI":"10.1172\/JCI129433","article-title":"17\u03b2-Estradiol and estrogen receptor \u03b1 protect right ventricular function in pulmonary hypertension via BMPR2 and apelin","volume":"131","author":"Frump","year":"2021","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib281","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/CIRCRESAHA.119.316339","article-title":"PPARgamma-p53-mediated Vasculoregenerative program to reverse pulmonary hypertension","volume":"128","author":"Hennigs","year":"2021","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100130_bib282","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1172\/JCI74773","article-title":"Systems-level regulation of microRNA networks by miR-130\/301 promotes pulmonary hypertension","volume":"124","author":"Bertero","year":"2014","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib283","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7150\/ijbs.34517","article-title":"Upregulation of miR-335-3p by NF-\u03baB transcriptional regulation contributes to the induction of pulmonary arterial hypertension via APJ during hypoxia","volume":"16","author":"Fan","year":"2020","journal-title":"Int J Biol Sci"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100130_bib284","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.rmed.2009.05.011","article-title":"Pulmonary apelin levels and effects in rats with hypoxic pulmonary hypertension","volume":"103","author":"Andersen","year":"2009","journal-title":"Respir Med"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100130_bib285","doi-asserted-by":"crossref","first-page":"e22431","DOI":"10.1096\/fj.202200266R","article-title":"Apela gene therapy alleviates pulmonary hypertension in rats","volume":"36","author":"Hu","year":"2022","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib286","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s12265-025-10612-3","article-title":"Mesenchymal stem cell-based apelin gene therapy improves pulmonary artery remodeling in monocrotaline-induced pulmonary hypertension through PI3K\/AKT\/eNOS and ERK1\/2 signaling pathways","volume":"18","author":"Wang","year":"2025","journal-title":"J Cardiovasc Transl Res"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100130_bib287","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1172\/JCI65592","article-title":"FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension","volume":"123","author":"Spiekerkoetter","year":"2013","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100130_bib288","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1164\/rccm.201412-2291OC","article-title":"Elafin reverses pulmonary hypertension via Caveolin-1-Dependent bone morphogenetic protein signaling","volume":"191","author":"Nickel","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib289","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ejheart.2005.10.007","article-title":"Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure","volume":"8","author":"Chong","year":"2006","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib290","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.yjmcc.2006.07.004","article-title":"Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II-angiotensin type 1 receptor system","volume":"41","author":"Iwanaga","year":"2006","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib291","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1253\/circj.CJ-11-0689","article-title":"Cardioprotective effect of apelin-13 on cardiac performance and remodeling in end-stage heart failure","volume":"76","author":"Koguchi","year":"2012","journal-title":"Circ J"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100130_bib292","doi-asserted-by":"crossref","first-page":"H931","DOI":"10.1152\/ajpheart.00703.2013","article-title":"Possible involvement of downregulation of the apelin-APJ system in doxorubicin-induced cardiotoxicity","volume":"308","author":"Hamada","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib293","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000249","article-title":"Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analogues","volume":"2","author":"Wang","year":"2013","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib294","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00726-020-02855-y","article-title":"Increased plasma level of apelin with NYHA grade II and III but not IV","volume":"52","author":"Han","year":"2020","journal-title":"Amino Acids"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100130_bib295","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3390\/jcm9072300","article-title":"Apelin improves prognostic value of HFSS (Heart Failure Survival Score) and MAGGIC (meta-analysis global group in chronic heart failure) scales in ambulatory patients with end-stage heart failure","volume":"9","author":"Szczurek","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib296","first-page":"23","article-title":"Discriminative utility of apelin-to-NT-pro-brain natriuretic peptide ratio for heart failure with preserved ejection fraction among type 2 diabetes mellitus patients","volume":"9","author":"Berezin","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.pharmr.2026.100130_bib297","doi-asserted-by":"crossref","first-page":"16104","DOI":"10.1038\/srep16104","article-title":"Apelin regulates FoxO3 translocation to mediate cardioprotective responses to myocardial injury and obesity","volume":"5","author":"Boal","year":"2015","journal-title":"Sci Rep"},{"issue":"1\u20133","key":"10.1016\/j.pharmr.2026.100130_bib298","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.regpep.2005.09.033","article-title":"Apelin protects myocardial injury induced by isoproterenol in rats","volume":"133","author":"Jia","year":"2006","journal-title":"Regul Pept"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100130_bib299","article-title":"Apelin has in vivo inotropic effects on normal and failing hearts","volume":"110","author":"Berry","year":"2004","journal-title":"Circulation"},{"issue":"26","key":"10.1016\/j.pharmr.2026.100130_bib300","doi-asserted-by":"crossref","first-page":"13006","DOI":"10.1073\/pnas.1900152116","article-title":"Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogs","volume":"116","author":"Wang","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmr.2026.100130_bib301","doi-asserted-by":"crossref","first-page":"170320","DOI":"10.1016\/j.peptides.2020.170320","article-title":"[MeArg1, NLe10]-apelin-12: optimization of solid-phase synthesis and evaluation of biological properties in vitro and in vivo","volume":"129","author":"Sidorova","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.pharmr.2026.100130_bib302","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.biomaterials.2014.08.045","article-title":"[Pyr1]-Apelin-13 delivery via nano-liposomal encapsulation attenuates pressure overload-induced cardiac dysfunction","volume":"37","author":"Serpooshan","year":"2015","journal-title":"Biomaterials"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100130_bib303","doi-asserted-by":"crossref","first-page":"127499","DOI":"10.1016\/j.bmcl.2020.127499","article-title":"Half-life extension of peptidic APJ agonists by N-terminal lipid conjugation","volume":"30","author":"Reed","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100130_bib304","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/CIRCRESAHA.124.324608","article-title":"Microparticle-mediated delivery of apelin improves heart function in post myocardial infarction mice","volume":"135","author":"Tang","year":"2024","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2026.100130_bib305","doi-asserted-by":"crossref","first-page":"583570","DOI":"10.3389\/fphys.2020.583570","article-title":"Apelin inhibits angiotensin ii-induced atrial fibrosis and atrial fibrillation via TGF-\u03b21\/Smad2\/\u03b1-SMA pathway","volume":"11","author":"Lv","year":"2020","journal-title":"Front Physiol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100130_bib306","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.015895","article-title":"Endothelial sirtuin 3 dictates glucose transport to cardiomyocyte and sensitizes pressure overload-induced heart failure","volume":"9","author":"Zeng","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pharmr.2026.100130_bib307","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fphar.2020.00256","article-title":"Icariin ameliorates diabetic cardiomyopathy through Apelin\/Sirt3 signalling to improve mitochondrial dysfunction","volume":"11","author":"Ni","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib308","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1002\/ctm2.693","article-title":"The microRNA-204-5p inhibits APJ signalling and confers resistance to cardiac hypertrophy and dysfunction","volume":"12","author":"Gaddam","year":"2022","journal-title":"Clin Transl Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib309","doi-asserted-by":"crossref","first-page":"141400","DOI":"10.1016\/j.ijbiomac.2025.141400","article-title":"LncRNA NAV2-AS2 is critical for fibroblast-to-myofibroblast transition and cardiac fibrosis","volume":"306","author":"Rong","year":"2025","journal-title":"Int J Biol Macromol"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100130_bib310","doi-asserted-by":"crossref","first-page":"10382","DOI":"10.1111\/jcmm.15651","article-title":"Apela improves cardiac and renal function in mice with acute myocardial infarction","volume":"24","author":"Pan","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.pharmr.2026.100130_bib311","doi-asserted-by":"crossref","first-page":"709467","DOI":"10.3389\/fphar.2021.709467","article-title":"Elabela protects spontaneously hypertensive rats from hypertension and cardiorenal dysfunctions exacerbated by dietary high-salt intake","volume":"12","author":"Sainsily","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100130_bib312","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijcard.2019.04.089","article-title":"Recombinant Fc-Elabela fusion protein has extended plasma half-life andmitigates post-infarct heart dysfunction in rats","volume":"292","author":"Xi","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmr.2026.100130_bib313","doi-asserted-by":"crossref","first-page":"873614","DOI":"10.3389\/fphar.2022.873614","article-title":"ELA-11 protects the heart against oxidative stress injury induced apoptosis through ERK\/MAPK and PI3K\/AKT signaling pathways","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100130_bib314","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2022.01.020","article-title":"Elabela alleviates ferroptosis, myocardial remodeling, fibrosis and heart dysfunction in hypertensive mice by modulating the IL-6\/STAT3\/GPX4 signaling","volume":"181","author":"Zhang","year":"2022","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib315","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1159\/000533277","article-title":"Canagliflozin ameliorates ventricular remodeling through Apelin\/angiotensin-converting enzyme 2 signaling in heart failure with preserved ejection fraction rats","volume":"108","author":"Zhang","year":"2023","journal-title":"Pharmacology"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100130_bib316","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3390\/biomedicines10071751","article-title":"The effect of SGLT2 inhibitor Dapagliflozin on serum levels of apelin in T2DM patients with heart failure","volume":"10","author":"Berezin","year":"2022","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100130_bib317","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.009693","article-title":"Proteomic analysis of effects of spironolactone in heart failure with preserved ejection fraction","volume":"15","author":"Javaheri","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pharmr.2026.100130_bib318","doi-asserted-by":"crossref","first-page":"175547","DOI":"10.1016\/j.ejphar.2023.175547","article-title":"Comprehensive analysis of the RNA transcriptome expression profiles and construction of the ceRNA network in heart failure patients with sacubitril\/valsartan therapeutic heterogeneity after acute myocardial infarction","volume":"944","author":"Su","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100130_bib319","doi-asserted-by":"crossref","first-page":"174892","DOI":"10.1016\/j.ejphar.2022.174892","article-title":"Montelukast, cysteinyl leukotriene receptor 1 antagonist, inhibits cardiac fibrosis by activating APJ","volume":"923","author":"Wu","year":"2022","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib320","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.3390\/ijms23042050","article-title":"Transcriptomic signatures of end-stage human dilated cardiomyopathy hearts with and without left ventricular assist device support","volume":"23","author":"Parikh","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2026.100130_bib321","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.yjmcc.2021.12.011","article-title":"MiR-185-5p regulates the development of myocardial fibrosis","volume":"165","author":"Lin","year":"2022","journal-title":"J Mol Cell Cardiol"},{"issue":"1\u20133","key":"10.1016\/j.pharmr.2026.100130_bib322","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.regpep.2005.05.004","article-title":"The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice","volume":"131","author":"Sorhede Winzell","year":"2005","journal-title":"Regul Pept"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib323","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/07435800903287079","article-title":"Apelin inhibits insulin secretion in pancreatic beta-cells by activation of PI3-kinase-phosphodiesterase 3B","volume":"34","author":"Guo","year":"2009","journal-title":"Endocr Res"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100130_bib324","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1055\/s-2006-948309","article-title":"Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects","volume":"114","author":"Li","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100130_bib325","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1210\/en.2014-1631","article-title":"Pancreatic islet APJ deletion reduces islet density and glucose tolerance in mice","volume":"156","author":"Han","year":"2015","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib326","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2337\/db11-0100","article-title":"Apelin treatment increases complete fatty acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice","volume":"61","author":"Attane","year":"2012","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib327","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.2337\/dc19-1865","article-title":"Plasma apelin and risk of type 2 diabetes in a cohort from the community","volume":"43","author":"Castan-Laurell","year":"2020","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100130_bib328","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/pedi.13101","article-title":"Adropin and apelin-12 efficiently predict metabolic syndrome in obese children","volume":"21","author":"Yin","year":"2020","journal-title":"Pediatr Diabetes"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib329","doi-asserted-by":"crossref","first-page":"152135","DOI":"10.1016\/j.imbio.2021.152135","article-title":"Regulatory role of Apelin-13-mediated PI3K\/AKT signaling pathway in the glucose and lipid metabolism of mouse with gestational diabetes mellitus","volume":"226","author":"Zheng","year":"2021","journal-title":"Immunobiology"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100130_bib330","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1080\/09513590.2020.1739264","article-title":"Circulating levels of Elabela and Apelin in the second and third trimesters of pregnancies with gestational diabetes mellitus","volume":"36","author":"Guo","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.pharmr.2026.100130_bib331","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12986-019-0389-9","article-title":"Dietary glycemic index and dietary glycemic load is associated with apelin gene expression in visceral and subcutaneous adipose tissues of adults","volume":"16","author":"Yuzbashian","year":"2019","journal-title":"Nutr Metab"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100130_bib332","doi-asserted-by":"crossref","first-page":"e14641","DOI":"10.14814\/phy2.14641","article-title":"L-carnitine improves metabolic disorders and regulates apelin and apelin receptor genes expression in adipose tissue in diabetic rats","volume":"8","author":"Ranjbar Kohan","year":"2020","journal-title":"Physiol Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib333","doi-asserted-by":"crossref","first-page":"2293409","DOI":"10.1080\/15592294.2023.2293409","article-title":"LncRNA NEAT1 aggravates human microvascular endothelial cell injury by inhibiting the Apelin\/Nrf2\/HO-1 signalling pathway in type 2 diabetes mellitus with obstructive sleep apnoea","volume":"19","author":"Chen","year":"2024","journal-title":"Epigenetics"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib334","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/2211-5463.12587","article-title":"Hypoxia exposure alleviates impaired muscular metabolism, glucose tolerance, and aerobic capacity in apelin-knockout mice","volume":"9","author":"He","year":"2019","journal-title":"FEBS Open Bio"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib335","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3892\/ijmm.2021.5008","article-title":"Apelin-13 alleviates diabetic nephropathy by enhancing nitric oxide production and suppressing kidney tissue fibrosis","volume":"48","author":"Gao","year":"2021","journal-title":"Int J Mol Med"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib336","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3892\/mmr.2025.13487","article-title":"Apelin\/APJ alleviates diabetic nephropathy by improving glomerular endothelial cells dysfunction via SIRT3-KLF15","volume":"31","author":"Huang","year":"2025","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.pharmr.2026.100130_bib337","doi-asserted-by":"crossref","first-page":"171333","DOI":"10.1016\/j.peptides.2024.171333","article-title":"Apelin\/APJ increased renal blood flow through endothelial BKCa channel induced p-eNOS and ET-1 in diabetic conditions","volume":"183","author":"Huang","year":"2025","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib338","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13098-024-01393-x","article-title":"RUNX3-activated apelin signaling inhibits cell proliferation and fibrosis in diabetic nephropathy by regulation of the SIRT1\/FOXO pathway","volume":"16","author":"Zhong","year":"2024","journal-title":"Diabetol Metab Syndr"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib339","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3892\/etm.2024.12398","article-title":"Expression of apelin-13 and its negative correlation with TGF-beta1 in patients with diabetic kidney disease","volume":"27","author":"Wang","year":"2024","journal-title":"Exp Ther Med"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100130_bib340","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1111\/jcmm.12619","article-title":"Apelin promotes diabetic nephropathy by inducing podocyte dysfunction via inhibiting proteasome activities","volume":"19","author":"Guo","year":"2015","journal-title":"J Cell Mol Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib341","doi-asserted-by":"crossref","first-page":"460","DOI":"10.7555\/JBR.37.20220214","article-title":"ELABELA protects against diabetic kidney disease by activating high glucose-inhibited renal tubular autophagy","volume":"37","author":"Zheng","year":"2023","journal-title":"J Biomed Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib342","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1007\/s10753-023-01882-7","article-title":"ELABELA\/APJ axis prevents diabetic glomerular endothelial injury by regulating AMPK\/NLRP3 pathway","volume":"46","author":"Chen","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.pharmr.2026.100130_bib343","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cca.2016.12.023","article-title":"Apelin\/APJ system: a novel promising therapy target for pathological angiogenesis","volume":"466","author":"Wu","year":"2017","journal-title":"Clin Chim Acta"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100130_bib344","doi-asserted-by":"crossref","first-page":"14680","DOI":"10.3390\/ijms232314680","article-title":"The protective role of apelin in the early stages of diabetic retinopathy","volume":"23","author":"Feng","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib345","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/13813455.2019.1680698","article-title":"Ramesh Babu K, Vadivelan M, Palanivel C. Association of serum omentin-1, apelin and chemerin concentrations with the presence and severity of diabetic retinopathy in type 2 diabetes mellitus patients","volume":"128","author":"Yasir","year":"2022","journal-title":"Arch Physiol Biochem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib346","doi-asserted-by":"crossref","first-page":"2259129","DOI":"10.1080\/08916934.2023.2259129","article-title":"Effects of Apelin on the fibrosis of retinal tissues and Muller cells in diabetes retinopathy through the JAK2\/STAT3 signalling pathway","volume":"56","author":"Li","year":"2023","journal-title":"Autoimmunity"},{"key":"10.1016\/j.pharmr.2026.100130_bib347","doi-asserted-by":"crossref","first-page":"1191891","DOI":"10.3389\/fcvm.2023.1191891","article-title":"Apelin prevents diabetes-induced poor collateral vessel formation and blood flow reperfusion in ischemic limb","volume":"10","author":"Robillard","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.pharmr.2026.100130_bib348","doi-asserted-by":"crossref","first-page":"110271","DOI":"10.1016\/j.biopha.2020.110271","article-title":"Apelin-13 attenuates high glucose-induced calcification of MOVAS cells by regulating MAPKs and PI3K\/AKT pathways and ROS-mediated signals","volume":"128","author":"Zhang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharmr.2026.100130_bib349","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.peptides.2019.03.006","article-title":"The effect of apelin-13 on pancreatic islet beta cell mass and myocardial fatty acid and glucose metabolism of experimental type 2 diabetic rats","volume":"114","author":"Feng","year":"2019","journal-title":"Peptides"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100130_bib350","doi-asserted-by":"crossref","first-page":"25120","DOI":"10.18632\/aging.104106","article-title":"Apelin protects against ischemia-reperfusion injury in diabetic myocardium via inhibiting apoptosis and oxidative stress through PI3K and p38-MAPK signaling pathways","volume":"12","author":"An","year":"2020","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib351","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/JOE-20-0398","article-title":"Apelin\/APJ relieve diabetic cardiomyopathy by reducing microvascular dysfunction","volume":"249","author":"Li","year":"2021","journal-title":"J Endocrinol"},{"key":"10.1016\/j.pharmr.2026.100130_bib352","doi-asserted-by":"crossref","first-page":"888948","DOI":"10.3389\/fendo.2022.888948","article-title":"Serum miRNA profile in diabetic patients with ischemic heart disease as a promising non-invasive biomarker","volume":"13","author":"Bielska","year":"2022","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib353","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/jcmm.16052","article-title":"Elabela may regulate SIRT3-mediated inhibition of oxidative stress through Foxo3a deacetylation preventing diabetic-induced myocardial injury","volume":"25","author":"Li","year":"2021","journal-title":"J Cell Mol Med"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib354","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/bab.2743","article-title":"Apelin-13 alleviates diabetes-associated cognitive decline by reducing oxidative stress and mitochondrial dysfunction via the SIRT3\/Foxo3 pathway","volume":"72","author":"Hu","year":"2025","journal-title":"Biotechnol Appl Biochem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib355","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12902-022-01051-1","article-title":"Low serum apelin levels are associated with mild cognitive impairment in Type 2 diabetic patients","volume":"22","author":"Jiang","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.pharmr.2026.100130_bib356","doi-asserted-by":"crossref","first-page":"155554","DOI":"10.1016\/j.cyto.2021.155554","article-title":"Expression and localization of apelin and its receptor in the testes of diabetic mice and its possible role in steroidogenesis","volume":"144","author":"Das","year":"2021","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib357","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1038\/s41467-022-34990-3","article-title":"Targeting APLN\/APJ restores blood-testis barrier and improves spermatogenesis in murine and human diabetic models","volume":"13","author":"Song","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2026.100130_bib358","doi-asserted-by":"crossref","first-page":"122517","DOI":"10.1016\/j.lfs.2024.122517","article-title":"Exercise and insulin glargine administration in mothers with diabetes during pregnancy ameliorate function of testis in offspring: consequences on apelin-13 and its receptor","volume":"342","author":"Mehri","year":"2024","journal-title":"Life Sci"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100130_bib359","doi-asserted-by":"crossref","first-page":"107601","DOI":"10.1016\/j.isci.2023.107601","article-title":"Elabela inhibits TRAF1\/NF-\u03baB induced oxidative DNA damage to promote diabetic foot ulcer wound healing","volume":"26","author":"Hong","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.pharmr.2026.100130_bib360","doi-asserted-by":"crossref","first-page":"110695","DOI":"10.1016\/j.mce.2019.110695","article-title":"Chronic apelin analogue administration is more effective than established incretin therapies for alleviating metabolic dysfunction in diabetic db\/db mice","volume":"504","author":"O'Harte","year":"2020","journal-title":"Mol Cell Endocrinol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100130_bib361","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1111\/dom.14177","article-title":"Beneficial actions of a long-acting apelin analogue in diabetes are related to positive effects on islet cell turnover and transdifferentiation","volume":"22","author":"Tanday","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib362","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13098-024-01332-w","article-title":"Enhancing insulin sensitivity in type 2 diabetes mellitus using apelin-loaded small extracellular vesicles from Wharton\u2019s jelly-derived mesenchymal stem cells: a novel therapeutic approach","volume":"16","author":"Cui","year":"2024","journal-title":"Diabetol Metab Syndr"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib363","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ki.2008.199","article-title":"Effect of apelin on glomerular hemodynamic function in the rat kidney","volume":"74","author":"Hus-Citharel","year":"2008","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100130_bib364","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1210\/en.2004-0384","article-title":"Dehydration-induced cross-regulation of apelin and vasopressin immunoreactivity levels in magnocellular hypothalamic neurons","volume":"145","author":"Reaux-Le Goazigo","year":"2004","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib365","doi-asserted-by":"crossref","first-page":"687","DOI":"10.33594\/000000165","article-title":"Apelin-13 regulates vasopressin-induced Aquaporin-2 expression and trafficking in kidney collecting duct cells","volume":"53","author":"Boulkeroua","year":"2019","journal-title":"Cell Physiol Biochem"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100130_bib366","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1210\/en.2014-1257","article-title":"Apelin counteracts vasopressin-induced water reabsorption via cross talk between apelin and vasopressin receptor signaling pathways in the rat collecting duct","volume":"155","author":"Hus-Citharel","year":"2014","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib367","first-page":"1","article-title":"Chraibi A Apelin-13 decreases epithelial sodium channel (ENaC) expression and activity in kidney collecting duct cells","volume":"56","author":"Ayari","year":"2022","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib368","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1681\/ASN.2007070816","article-title":"Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli","volume":"19","author":"Azizi","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100130_bib369","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.bbadis.2015.02.013","article-title":"Apelin protects against acute renal injury by inhibiting TGF-beta1","volume":"1852","author":"Chen","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100130_bib370","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1681\/ASN.2016111210","article-title":"ELABELA and an ELABELA fragment protect against AKI","volume":"28","author":"Chen","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmr.2026.100130_bib371","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jss.2019.09.063","article-title":"Remote ischemic Perconditioning modulates apelin expression after renal ischemia-reperfusion injury","volume":"247","author":"Gholampour","year":"2020","journal-title":"J Surg Res"},{"key":"10.1016\/j.pharmr.2026.100130_bib372","doi-asserted-by":"crossref","first-page":"1544274","DOI":"10.3389\/fphys.2025.1544274","article-title":"Insights into the effects of apelin-13 on renal function and NHE3 activity following ischemia\/reperfusion-induced acute kidney injury","volume":"16","author":"Lopes-Goncalves","year":"2025","journal-title":"Front Physiol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib373","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.transproceed.2017.03.080","article-title":"Protective role of Apelin Against cyclosporine-induced renal tubular injury in rats","volume":"49","author":"Kim","year":"2017","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib374","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3892\/etm.2012.499","article-title":"Effects of apelin and leptin on renal functions following renal ischemia\/reperfusion: an experimental study","volume":"3","author":"Sagiroglu","year":"2012","journal-title":"Exp Ther Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100130_bib375","doi-asserted-by":"crossref","first-page":"e70319","DOI":"10.1096\/fj.202402850R","article-title":"Apelin-13 inhibits ischemia-reperfusion mediated podocyte apoptosis by reducing m-TOR phosphorylation to enhance autophagy","volume":"39","author":"Zheng","year":"2025","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmr.2026.100130_bib376","doi-asserted-by":"crossref","first-page":"170682","DOI":"10.1016\/j.peptides.2021.170682","article-title":"Effect of Fc-Elabela-21 on renal ischemia\/reperfusion injury in mice: mediation of anti-apoptotic effect via Akt phosphorylation","volume":"147","author":"Xu","year":"2022","journal-title":"Peptides"},{"issue":"10159","key":"10.1016\/j.pharmr.2026.100130_bib377","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016\u201340 for 195 countries and territories","volume":"392","author":"Foreman","year":"2018","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100130_bib378","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/ajhp\/zxaf044","article-title":"KDIGO 2024 clinical practice guideline on evaluation and management of chronic kidney disease: A primer on what pharmacists need to know","volume":"82","author":"Awdishu","year":"2025","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib379","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2215\/CJN.0000000588","article-title":"Residual risk of adverse kidney and cardiovascular outcomes in patients with CKD","volume":"20","author":"Khan","year":"2025","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100130_bib380","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41581-021-00461-z","article-title":"The therapeutic potential of apelin in kidney disease","volume":"17","author":"Chapman","year":"2021","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100130_bib381","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1113\/jphysiol.2013.266411","article-title":"Apelin inhibits the development of diabetic nephropathy by regulating histone acetylation in Akita mouse","volume":"592","author":"Chen","year":"2014","journal-title":"J Physiol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100130_bib382","doi-asserted-by":"crossref","first-page":"F788","DOI":"10.1152\/ajprenal.00306.2012","article-title":"Apelin retards the progression of diabetic nephropathy","volume":"304","author":"Day","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100130_bib383","doi-asserted-by":"crossref","first-page":"e13939","DOI":"10.14814\/phy2.13939","article-title":"Apelinergic system in the kidney: implications for diabetic kidney disease","volume":"6","author":"Muller","year":"2018","journal-title":"Physiol Rep"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100130_bib384","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/s41419-018-1098-4","article-title":"Apelin inhibited epithelial-mesenchymal transition of podocytes in diabetic mice through downregulating immunoproteasome subunits \u03b25i","volume":"9","author":"Yin","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.pharmr.2026.100130_bib385","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.peptides.2019.04.005","article-title":"Elabela protects against podocyte injury in mice with streptozocin-induced diabetes by associating with the PI3K\/Akt\/mTOR pathway","volume":"114","author":"Zhang","year":"2019","journal-title":"Peptides"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100130_bib386","doi-asserted-by":"crossref","first-page":"e3006","DOI":"10.1038\/cddis.2017.414","article-title":"Apelin involved in progression of diabetic nephropathy by inhibiting autophagy in podocytes","volume":"8","author":"Liu","year":"2017","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100130_bib387","doi-asserted-by":"crossref","first-page":"e60457","DOI":"10.1371\/journal.pone.0060457","article-title":"Promoting effects of the adipokine, apelin, on diabetic nephropathy","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100130_bib388","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1096\/fj.201701257R","article-title":"Apelin impairs myogenic response to induce diabetic nephropathy in mice","volume":"32","author":"Zhang","year":"2018","journal-title":"FASEB J"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100130_bib389","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1007\/s00726-014-1826-8","article-title":"The regulatory peptide apelin: a novel inhibitor of renal interstitial fibrosis","volume":"46","author":"Wang","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.pharmr.2026.100130_bib390","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.peptides.2017.08.006","article-title":"Apelin attenuates TGF-beta1-induced epithelial to mesenchymal transition via activation of PKC-epsilon in human renal tubular epithelial cells","volume":"96","author":"Wang","year":"2017","journal-title":"Peptides"},{"key":"10.1016\/j.pharmr.2026.100130_bib391","doi-asserted-by":"crossref","first-page":"5012474","DOI":"10.1155\/2023\/5012474","article-title":"The interaction of apelin and FGFR1 ameliorated the kidney fibrosis through suppression of TGFbeta-induced endothelial-to-mesenchymal transition","volume":"2023","author":"Gao","year":"2023","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib392","doi-asserted-by":"crossref","first-page":"F1122","DOI":"10.1152\/ajprenal.00606.2019","article-title":"ELABELA antagonizes intrarenal renin-angiotensin system to lower blood pressure and protects against renal injury","volume":"318","author":"Xu","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100130_bib393","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000337091","article-title":"The role of apelin on the alleviative effect of angiotensin receptor blocker in unilateral ureteral obstruction-induced renal fibrosis","volume":"2","author":"Nishida","year":"2012","journal-title":"Nephron Extra"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib394","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2174\/1566523217666161121111906","article-title":"Sustained ELABELA gene therapy in high-salt diet-induced hypertensive rats","volume":"16","author":"Schreiber","year":"2017","journal-title":"Curr Gene Ther"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100130_bib395","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41419-020-02933-9","article-title":"Correction: ELABELA attenuates deoxycorticosterone acetate\/salt-induced hypertension and renal injury by inhibition of NADPH oxidase\/ROS\/NLRP3 inflammasome pathway","volume":"11","author":"\u2018Chen","year":"2020","journal-title":"Cell Death Dis"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib396","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1210\/jc.2012-3794","article-title":"An abnormal apelin\/vasopressin balance may contribute to water retention in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) and heart failure","volume":"98","author":"Blanchard","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib397","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1210\/jc.2016-1158","article-title":"Plasma apelin concentrations in patients with polyuria-polydipsia syndrome","volume":"101","author":"Urwyler","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100130_bib398","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/ejendo\/lvae138","article-title":"Apelin levels in patients with polyuria-polydipsia syndrome upon copeptin stimulation tests","volume":"191","author":"Bizzozero","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pharmr.2026.100130_bib399","doi-asserted-by":"crossref","first-page":"123980","DOI":"10.1016\/j.lfs.2025.123980","article-title":"Effects of apelin on age-associated neovascularization impairment in peripheral artery disease","volume":"381","author":"Chen","year":"2025","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmr.2026.100130_bib400","doi-asserted-by":"crossref","first-page":"123438","DOI":"10.1016\/j.biomaterials.2025.123438","article-title":"Targeted delivery of apelin using a novel extracellular vesicle platform for pulmonary arterial hypertension treatment","volume":"323","author":"Kim","year":"2025","journal-title":"Biomaterials"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100130_bib401","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s40265-020-01414-9","article-title":"Oliceridine: first approval","volume":"80","author":"Markham","year":"2020","journal-title":"Drugs"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T10:36:48Z","timestamp":1779446208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699726000189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":400,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0031699726000189"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100130","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International Union of Basic and Clinical Pharmacology. CXXI. Apelin receptor pharmacology in the human cardiovascular system and emerging clinical applications","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100130"}}